It also deactivated the TLR4/NF-κB partially mediated signaling pathway (Cao et al., 2022) and modulates the obesity-induced inflammatory response (Rogero and Calder, 2018). The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.